Treatment of atopic dermatitis with indigo naturalis or indigo producing plant extract

Patent metadata

Field	Value
Publication number	US-9833438-B2
Application number	US-201715634489-A
Country	US
Kind code	B2
Filing date	Jun 27, 2017
Priority date	Apr 9, 2015
Publication date	Dec 5, 2017
Grant date	Dec 5, 2017

Abstract

A pharmaceutical or cosmetic composition comprising an Indigo Naturalis or Indigo-producing plant extract for treating atopic dermatitis and any form of eczema, and a method of treating atopic dermatitis comprising administering a therapeutically effective amount of an Indigo Naturalis or Indigo-producing plant extract to a subject in need thereof are described.

First claim

The invention claimed is:

1. A method of treating an atopic dermatitis, comprising administering to a subject in need thereof a pharmaceutical composition comprising a solid extract of Indigo Naturalis and a pharmaceutically acceptable carrier,
wherein the solid extract comprises, relative to the total weight of the extract:
65% to 90% (w/w) indirubin;
0.1-15% (w/w) indigo; and
0.01-5% (w/w) at least one of tryptanthrin and qingdainone.

2. The method of claim 1 , wherein the pharmaceutical composition comprises 0.01 to 10 mg of the solid extract of Indigo Naturalis per 1 g of the pharmaceutical composition.

3. The method of claim 1 , wherein the solid extract comprises 0.1-5% (w/w) tryptanthrin and 0.1-5% (w/w) qingdainone relative to the total weight of the extract.

4. The method of claim 1 , wherein the solid extract is micronized and comprises particles having a particle size of 25 to 35 μm in 99% of the particles.

5. The method of claim 1 , wherein the pharmaceutical composition is in the form for topical administration.

6. The method of claim 1 , further comprising administering to the subject in need thereof at least one selected from the group consisting of a corticosteroid, a calcineurin inhibitor and a phosphodiesterase inhibitor.

7. The method of claim 1 , wherein the pharmaceutical composition further comprises at least one selected from the group consisting of a corticosteroid, a calcineurin inhibitor and a phosphodiesterase inhibitor.

8. The method of claim 1 , wherein the subject is 25 years old or younger.

9. A method of treating an atopic dermatitis, comprising topically administering to a subject in need thereof, once or twice daily, a pharmaceutical composition comprising a solid extract of Indigo Naturalis and a pharmaceutically acceptable carrier,
wherein the pharmaceutical composition comprises 0.01 to 10 mg of the solid extract per 1 g of the pharmaceutical composition, and
the solid extract comprises, relative to the total weight of the extract:
65% to 90% (w/w) indirubin;
0.1-15% (w/w) indigo; and
0.01-5% (w/w) at least one of tryptanthrin and qingdainone.

10. The method of claim 9 , wherein the solid extract comprises 0.1-5% (w/w) tryptanthrin and 0.1-5% (w/w) qingdainone relative to the total weight of the extract.

11. The method of claim 9 , wherein the solid extract is micronized and comprises particles having a particle size of 25 to 35 μm in 99% of the particles.

12. The method of claim 9 , further comprising administering to the subject at least one selected from the group consisting of a corticosteroid, a calcineurin inhibitor and a phosphodiesterase inhibitor.

13. The method of claim 9 , wherein the pharmaceutical composition further comprises at least one selected from the group consisting of a corticosteroid, a calcineurin inhibitor and a phosphodiesterase inhibitor.

14. The method of claim 9 , wherein the subject is 25 years old or younger.

15. A method of treating an atopic dermatitis, comprising administering to a subject in need thereof a pharmaceutical composition comprising a solid extract of Indigo Naturalis and a pharmaceutically acceptable carrier,
wherein the solid extract is prepared from Indigo Naturalis by a process comprising:
a) extracting the Indigo Naturalis with a solvent to obtain a mixture of extraction, wherein the solvent is selected from the group consisting of dimethylformamide, ethyl acetate, ethanol, dimethylsulfoxide, dichloromethane, tetrahydrofuran, dimethylacetamide, acetone, 2-butanone, acetonitrile, isopropyl acetate, 2-methyl tetrahydrofuran, methyl tert-butyl ether, methanol, chloroform, terpene, water and a combination thereof,
b) filtering the mixture of extraction to obtain a filtrate,
c) concentrating the filtrate to obtain a crude extract,
d) mixing the crude extract with hexane or heptane to obtain a washing mixture, and
e) filtering the washing mixture to obtain the solid extract.

16. The method of claim 15 , wherein the solvent used in a) is selected from the group consisting of dimethylformamide, ethyl acetate, ethanol, and a combination thereof, or an aqueous solution thereof.

17. The method of claim 16 , wherein in d), the crude extract is mixed with hexane or heptane at a temperature not less than 50° C. to obtain the washing mixture.

18. The method of claim 17 , wherein in e), the washing mixture is cooled and filtered at room temperature to obtain the solid extract.

19. The method of claim 15 , wherein the solid extract is prepared from Indigo Naturalis by the process comprising:
a) extracting the Indigo Naturalis with a solvent to obtain a mixture of extraction, wherein the solvent is selected from the group consisting of ethyl acetate, ethanol, an aqueous solution of ethanol, and a combination thereof, and the mixture of extraction is obtained by mixing the Indigo Naturalis and the solvent in reflux,
b) filtering the mixture of extraction at a temperature of not less than 65° C. to obtain a filtrate,
c) concentrating the filtrate to obtain a crude extract,
d) mixing the crude extract and hexane in reflux to obtain a first washing mixture,
e) cooling and filtering the first washing mixture at room temperature to obtain a first extract product, and
f) washing the first extract product with a washing method comprising:
a) mixing the first extract product and a solvent selected from the group consisting of hexane, ethanol and an aqueous solution of ethanol in reflux to obtain a second washing mixture,
b) cooling and filtering the second washing mixture at room temperature to obtain a second extract product, and
c) drying the second extract product at a temperature of less than 80° C. to obtain a dried extract product,

g) optionally washing the dried extract product with the washing method of f) one or more times to thereby obtain the solid extract.

20. The method of claim 19 , wherein the process further comprises micronizing the solid extract.

Assignees

• Galderma Sa

Inventors

• Andres Philippe
• Chantalat Laurent
• Lin Yin-Ku

Classifications

• A61P37/08

  Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

• A61K36/70

  Polygonaceae (Buckwheat family), e.g. spineflower or dock · CPC title

• A61K2236/33

  involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones · CPC title

• A61K2236/53

  Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization · CPC title

• A61K31/404 Primary

  Indoles, e.g. pindolol · CPC title